SEARCH

SEARCH BY CITATION

References

  • Ben-Ari Y, Holmes GL. (2006) Effects of seizures on developmental processes in the immature brain. Lancet Neurol 5:10551063.
  • Benedetti MS, Coupez R, Whomsley R, Nicolas JM, Collart P, Baltes E. (2004) Comparative pharmacokinetics and metabolism of levetiracetam, a new anti-epileptic agent, in mouse, rat, rabbit and dog. Xenobiotica 34:281300.
  • Birnstiel S, Wülfert E, Beck SG. (1997) Levetiracetam (ucb LO59) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission. Naunyn Schmiedebergs Arch Pharmacol 356:611618.
  • Blumenfeld H. (2005) Cellular and network mechanisms of spike-wave seizures. Epilepsia 46:2133.
  • Blumenfeld H, Klein JP, Schridde U, Vestal M, Rice T, Khera DS, Bashyal C, Giblin K, Paul-Laughinghouse C, Wang F, Phadke A, Mission J, Agarwal RK, Englot DJ, Motelow J, Nersesyan H, Waxman SG, Levin AR. (2008) Early treatment suppresses the development of spike-wave epilepsy in a rat model. Epilepsia 49:400409.
  • Bouwman BM, Van Rijn CM. (2004) Effects of levetiracetam on spike and wave discharges in WAG/Rij rats. Seizure 13:591594.
  • Chen K, Baram TZ, Soltesz I. (1999) Febrile seizures in the developing brain result in persistent modification of neuronal excitability in limbic circuits. Nat Med 5:888894.
  • Coenen AM, Van Luijtelaar EL. (2003) Genetic animal models for absence epilepsy: a review of the WAG/Rij strain of rats. Behav Genet 33:635655.
  • Commission on Classification and Terminology of the International League Against Epilepsy. (1989) Proposal for a revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389399.
  • Dedeurwaerdere S, Boon P, De Smedt T, Claeys P, Raedt R, Bosman T, Van Hese P, Van Maele G, Vonck K. (2005) Chronic levetiracetam treatment early in life decreases epileptiform events in young GAERS, but does not prevent the expression of spike and wave discharges during adulthood. Seizure 14:403411.
  • De Zwart L, Scholten M, Monbaliu JG, Annaert PP, Van Houdt JM, Van den Wyngaert I, De Schaepdrijver LM, Bailey GP, Coogan TP, Coussement WC, Mannens GS. (2008) The ontogeny of drug metabolizing enzymes and transporters in the rat. Reprod Toxicol 26:220230.
  • Fountain NB, Conry JA, Rodríguez-Leyva I, Gutierrez-Moctezuma J, Salas E, Coupez R, Stockis A, Lu ZS. (2007) Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate. Epilepsy Res 74:6069.
  • Gambardella A, Labate A, Colosimo E, Ambrosio R, Quattrone A. (2008) Monotherapy for partial epilepsy: focus on levetiracetam. Neuropsychiatr Dis Treat 4:3338.
  • Gilbert TH, Teskey GC. (2007) Conventional anticonvulsant drugs in the guinea-pig kindling model of partial seizures: effects of repeated administration. Exp Brain Res 178:115125.
  • Gören MZ, Onat F. (2007) Ethosuximide: from bench to bedside. CNS Drug Rev 13:224239.
  • Gower AJ, Hirsch E, Boehrer A, Noyer M, Marescaux C. (1995) Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy. Epilepsy Res 22:207213.
  • Kaminski RM, Gillard M, Leclercq K, Hanon E, Lorent G, Dassesse D, Matagne A, Klitgaard H. (2009) Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam. Epilepsia 50: 17291740.
  • Karler R, Murphy V, Calder LD, Turkanis SA. (1989) Pentylenetetrazol kindling in mice. Neuropharmacology 28:775780.
  • Klitgaard H, Matagne A, Gobert J, Wulfert E. (1998) Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur J Pharmacol 353:191206.
  • Klitgaard H, Pitkanen A. (2003) Antiepileptogenesis, neuroprotection, and disease modification in the treatment of epilepsy: focus on levetiracetam. Epileptic Disord 5:S9S16.
  • Kole MH, Bräuer AU, Stuart GJ. (2007) Inherited cortical HCN1 channel loss amplifies dendritic calcium electrogenesis and burst firing in a rat absence epilepsy model. J Physiol 15:507525.
  • Liu XB, Coble J, Van Luijtelaar G, Jones EG. (2007) Reticular nucleus-specific changes in alpha3 subunit protein at GABA synapses in genetically epilepsy-prone rats. Proc Natl Acad Sci USA 24:1251212517.
  • Löscher W, Schmidt D. (1988) Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 2:145181.
  • Löscher W, Hönack D, Rundfeldt C. (1998) Antiepileptic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal epilepsy. J Pharmacol Exp Ther 285:474479.
  • Löscher W, Hönack D. (1993) Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats. Eur J Pharmacol 232:147158.
  • Löscher W, Hönack D. (2000) Development of tolerance during chronic treatment of kindled rats with the novel antiepileptic drug levetiracetam. Epilepsia 41:14991506.
  • Lukyanetz EA, Shkryl VM, Kostyuk PG. (2002) Selective blockade of N-type calcium channels by levetiracetam. Epilepsia 43:918.
  • Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B. (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. PNAS 101:98619866.
  • Madeja M, Margineanu DG, Gorji A, Siep E, Boerrigter P, Klitgaard H, Speckmann EJ. (2003) Reduction of voltage operated potassium currents by levetiracetam: a nove antiepileptic mechanism of action? Neuropharmacology 45:661671.
  • Margineanu DG, Matagne A, Kaminski RM, Klitgaard H. (2008) Effects of chronic treatment with levetiracetam on hippocampal field responses after pilocarpine-induced status epilepticus in rats. Brain Res Bull. 77: 282285.
  • Martella G, Costa C, Pisani A, Cupini LM, Bernardi G, Calabresi P. (2008) Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine. Cephalalgia 28:13151326.
  • McNamara JO. (2003) Farmaci per la terapia delle epilessie. In HardmanJG, LimbirdLE (Eds) Goodman & Gilman. Le basi farmacologiche della terapia, X edizione. McGraw-Hill, Milan, Italy, pp. 499524.
  • Meeren HK, Pijn JP, Van Luijtelaar EL, Coenen AM, Lopes da Silva FH. (2002) Cortical focus drives widespread corticothalamic networks during spontaneous absence seizures in rats. J Neurosci 22:14801495.
  • Merlo D, Mollinari C, Inaba Y, Cardinale A, Rinaldi AM, D’Antuono M, D’Arcangelo G, Tancredi V, Ragsdale D, Avoli M. (2007) Reduced GABAB receptor subunit expression and paired-pulse depression in a genetic model of absence seizures. Neurobiol Dis 25:631641.
  • Micheva KD, Beaulieu C. (1995) Postnatal development of GABA neurons in the rat somatosensory barrel cortex: a quantitative study. Eur J Neurosci 7:419430.
  • Mifsud J, Millership JS, Collier PS, Morrow R, Hamilton JT, McRoberts WC. (2001) Quantification of urinary excretion of ethosuximide enantiomers and their major metabolites in the rat. Biopharm Drug Dispos 22:129136.
  • Morimoto K, Fahnestock M, Racine RJ. (2004) Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol 73:160.
  • Ngomba RT, Biagioni F, Casciato S, Willems-van Bree E, Battaglia G, Bruno V, Nicoletti F, Van Luijtelaar EL. (2005) The preferential mGlu2/3 receptor antagonist, LY341495, reduces the frequency of spike-wave discharges in the WAG/Rij rat model of absence epilepsy. Neuropharmacology 49:89103.
  • Ngomba RT, Ferraguti F, Badura A, Citraro R, Santolini I, Battaglia G, Bruno V, De Sarro G, Simonyi A, Van Luijtelaar G, Nicoletti F. (2008) Positive allosteric modulation of metabotropic glutamate 4 (mGlu4) receptors enhances spontaneous and evoked absence seizures. Neuropharmacology 54:344354.
  • Niespodziany I, Klitgaard H, Margineanu DG. (2001) Levetiracetam inhibits the high-voltage-activated Ca(2+) current in pyramidal neurones of rat hippocampal slices. Neurosci Lett 306:58.
  • Paxinos G, Watson C. (1998) The rat brain in stereotaxic coordinates. 4th ed. Academic Press, San Diego, CA.
  • Pisani A, Bonsi P, Martella G, De Persis C, Costa C, Pisani F, Bernardi G, Calabresi P. (2004) Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine. Epilepsia 45:719728.
  • Pisu MG, Mostallino MC, Dore R, Mura ML, Maciocco E, Russo E, De Sarro G, Serra M. (2008) Neuroactive steroids and GABAA receptor plasticity in the brain of the WAG/Rij rat, a model of absence epilepsy. J Neurochem 106:25022514.
  • Posner EB, Mohamed K, Marson AG. (2003) Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database Syst Rev Issue 4. Art. No.: CD003032.
  • Rigo JM, Hans G, Nguyen L, Rocher V, Belachew S, Malgrange B, Leprince P, Moonen G, Selak I, Matagne A, Klitgaard H. (2002) The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents. Br J Pharmacol 136:659672.
  • Ritter LM, Vazquez DM, Meador-Woodruff JH. (2002) Ontogeny of ionotropic glutamate receptor subunit expression in the rat hippocampus. Brain Res Dev Brain Res 139:227236.
  • Russo E, Constanti A, Ferreri G, Citraro R, De Sarro G. (2004) Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy. Neuropharmacology 46:865878.
  • Russo E, Citraro R, De Fazio S, Marra R, Gitto R, Chimirri A, De Sarro G, Di Paola ED. (2008) Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy. Epilepsy Behav 13:295299.
  • Sarver JG, Bachmann KA, Zhu D, Klis WA. (1998) Ethosuximide is primarily metabolized by CYP3A when incubated with isolated rat liver microsomes. Drug Metab Dispos 26:7882.
  • Sasa M. (2006) A new frontier in epilepsy: novel antiepileptogenic drugs. J Pharmacol Sci 100:487494.
  • Schridde U, Strauss U, Bräuer AU, Van Luijtelaar G. (2006) Environmental manipulations early in development alter seizure activity, Ih and HCN1 protein expression later in life. Eur J Neurosci 23:33463358.
  • Sharma V, Babu PP, Singh A, Singh S, Singh R. (2007) Iron-induced experimental cortical seizures: electroencephalographic mapping of seizure spread in the subcortical brain areas. Seizure 16:680690.
  • Tsenov G, Redkozubova O, Kubová H, Mareš P. (2009) Effects of lamotrigine on cortically-elicited phenomena in adult rats: differences between acute application and late consequences of early postnatal administration. Brain Res 1258:6570.
  • Van De Bovenkamp-Janssen MC, Scheenen WJ, Kuijpers-Kwant FJ, Kozicz T, Veening JG, Van Luijtelaar EL, McEnery MW, Roubos EW. (2004) Differential expression of high voltage-activated Ca2+ channel types in the rostral reticular thalamic nucleus of the absence epileptic WAG/Rij rat. J Neurobiol 58:467478.
  • Van De Bovenkamp-Janssen MC, Van Der Kloet JC, Van Luijtelaar G, Roubos EW. (2006) NMDA-NR1 and AMPA-GluR4 receptor subunit immunoreactivities in the absence epileptic WAG/Rij rat. Epilepsy Res 69:119128.
  • Van Luijtelaar G, Sitnikova E. (2006) Global and focal aspects of absence epilepsy: the contribution of genetic models. Neurosci Biobehav Rev 30:9831003.
  • Van Rijn CM, Sun MS, Deckers CL, Edelbroek PM, Keyser A, Renier W, Meinardi H. (2004) Effects of the combination of valproate and ethosuximide on spike wave discharges in WAG/Rij rats. Epilepsy Res 59:181189.
  • Van Vliet EA, Van Schaik R, Edelbroek PM, Da Silva FH, Wadman WJ, Gorter JA. (2008) Development of tolerance to levetiracetam in rats with chronic epilepsy. Epilepsia 49:11511159.
  • Van Vliet EA, Aronica E, Redeker S, Boer K, Gorter JA. (2009) Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy. Epilepsia 50:422433.
  • Van Zutphen LF, Baumans V, Beynen AC. (2001) Principles of laboratory animal science, Rev ed. Elsevier, Amsterdam.
  • Vergnes M, Marescaux C, Depaulis A, Micheletti G, Warter JM. (1986) Ontogeny of spontaneous petit mal-like seizures in Wistar rats. Brain Res 395:8587.
  • Wahle H, Frey HH. (1990) Development of tolerance to the anticonvulsant effect of valproate but not to ethosuximide in a rat model of absence epilepsy. Eur J Pharmacol 31:18.
  • Yang XF, Weisenfeld A, Rothman SM. (2007) Prolonged exposure to levetiracetam reveals a presynaptic effect on neurotransmission. Epilepsia 48:18611869.
  • Yu ZY, Wang W, Fritschy JM, Witte OW, Redecker C. (2006) Changes in neocortical and hippocampal GABAA receptor subunit distribution during brain maturation and aging. Brain Res 1099:7381.
  • Zona C, Niespodziany I, Marchetti C, Klitgaard H, Bernardi G, Margineanu DG. (2001) Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca2+ currents. Seizure 10:279286.